Company / Operating Cash Flow per Share
ORAMED PHARMACEUTICALS INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.21
FY2025
5-year range
-$0.71 / -$0.21
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.74 in FY2020 to $0.34 in FY2018.
Based on SEC 10-K filings.
-0.21 in FY2025.
Improved from $-0.71 to $-0.21 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 17.4% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.21 | +17.4% |
| FY2024 | -$0.26 | +63.8% |
| FY2023 | -$0.71 | -27.1% |
| FY2022 | -$0.56 | -5.6% |
| FY2021 | -$0.53 | +29.4% |
| FY2020 | -$0.74 | -121.7% |
| FY2019 | -$0.34 | -198.6% |
| FY2018 | $0.34 | +190.8% |
| FY2017 | -$0.38 | -6.6% |
| FY2016 | -$0.35 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026